From Name:
From Email:
To Name:
To Email:

Optional Message:


National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States

from PNAS

Vaccination protects against human papilloma virus-induced cervical cancer, but coverage varies markedly across the United States. The nonavalent vaccine produces greater health benefits than the bivalent and quadrivalent vaccines at a lower societal cost. Because of the impact of herd immunity, any expansion in coverage will be much more effective in reducing cancer incidence and healthcare costs if targeted in those states with the lowest coverage. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063